Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantationIntravascular ultrasound studies

Journal of Diabetes and its Complications

Volumn 16, Issue 1, 2002, Pages 50-55

  Takagi, Tsutomu ^a   Akasaka, Takashi ^b   Yamamuro, Atsushi ^a   Honda, Yasuhiro ^a   Hozumi, Takeshi ^a   Morioka, Shigefumi ^a   Yoshida, Kiyoshi ^b  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Insulin resistance; Intravascular ultrasound; Neointimal tissue proliferation; Stent; Troglitazone

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; CORONARY STENT; HUMAN; HYPERINSULINEMIA; IMMUNOREACTIVITY; INSULIN RESISTANCE; INTRAVASCULAR ULTRASOUND; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RESTENOSIS; ULTRASOUND; WORLD HEALTH ORGANIZATION;

BLOOD GLUCOSE; CELL DIVISION; CORONARY RESTENOSIS; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; STENTS; TUNICA INTIMA;

EID: 0036183389     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(01)00190-8     Document Type: Conference Paper

References (27)

1. Restenosis after arterial injury caused by coronary stents in patients with diabetes mellitus
2. Pathology of acute and chronic coronary stenting in humans
3. Troglitazone inhibits angiotensin II induced DNA synthesis and migration in vascular smooth muscle cells
4. Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes
5. Patterns and mechanism of in-stent restenosis. A serial intravascular ultrasound study
6. Predictive factors of restenosis after coronary stent placement
7. Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells
8. Remodeling of human coronary arteries undergoing coronary angioplasty of atherectomy
9. Three-year clinical follow-up after Palmatz-Schatz stenting
10. Neointimal tissue response at site of coronary stenting in human: macroscopic, histological and immunohistological analysis
11. Increased restenosis in diabetes mellitus after coronary intervention is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study
12. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
13. Pioglitazone 026 study group. The effect of pioglitazone on glucose control and lipid profile in patients with type 2 diabetes
14. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study
15. Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes
16. Enhanced secretion of insulin plays role in the development of atherosclerosis and restenosis of coronary artery in patients with effort angina
17. Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus
18. Differential inhibitory effects of antidiabetic drugs on arterial smooth muscle sell proliferation
19. Effect of insulin on growth factors of cultured human arterial smooth muscle cells
20. Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats
21. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cell
22. Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study
23. Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study
24. Report of WHO Study Group. Definition, diagnosis, and classification: diabetes mellitus
25. Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells
26. Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy